MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on SilverScript Choice (S5601-024)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Alabama + 1 more
Premium
$97.30/month
Deductible
$615.00
Change plan

6 of 8 Non-statin cholesterol drugs are covered on this plan. 1 of them require prior authorization.

2 aren't on the formulary (Praluent and icosapent ethyl).

  • ezetimibe
    generic Zetia
    Covered
    33%
    Tier 4
  • Repatha
    evolocumab
    Covered · prior auth
    18%
    Tier 3
  • Nexletol
    bempedoic acid
    Covered
    $76.64
    Tier 3
  • Nexlizet
    bempedoic acid and ezetimibe
    Covered
    $76.64
    Tier 3
  • fenofibrate
    generic Tricor
    Covered
    $7.00
    Tier 2
  • Vascepa
    icosapent ethyl
    Covered
    33%
    Tier 4
Not on the formulary
Praluent, icosapent ethyl

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list